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Objectives: Hydrogen sulﬁde (H2S) has been
described as a pharmacologic adjunct to minimize
ischemia-reperfusion injury (IRI). We sought to evaluate
the impact of H2S in a validated hindlimb ischemia model.
Methods: Forty swine (weight: 69 6 7.2 [standard
deviation] kg) were randomized to iliac artery occlusion
for 0, 3, or 6 hours of ischemia, followed by vessel repair,
and systemic infusion of H2S (10 mg/kg/h) or normal sa-
line for 2 hours after reperfusion. Animals were survived for
14 days with serial evaluation of systemic injury markers,
gait analysis, motor, and sensory nerve action potentials,
and histopathology.
Results: Baseline physiologic characteristics were
similar between groups. At 0 hours of ischemia, H2S
increased aspartate transaminase (AST; 125.68 6 58.36
IU/L vs 303.78 6 129.58 IU/L; P < .001), creatinine
phosphokinase (CK; 12014.17 6 8181.9 mg/L vs
28667.89 6 18883.18 mg/L; P < .001), and lactate dehy-
drogenase (LDH; 1107.67 6 754.13 U/L vs 1954.33 6
910.25 U/L; P¼ .004) on postoperative day (POD) 1. An-
imals receivingH2S at 3 hours of ischemia had lower AST on
POD1 (627.436 486.6 IU/Lvs 1162.436580.58 IU/L;
P < .05) and lower CK on POD 2 (27313.17 6 18151.19
mg/L vs 64230.71640503.18mg/L;P< .05). LDH levels
were signiﬁcantly lower in 3-hour and 6-hour ischemia H2S
groups on POD 1 (P< .05). No signiﬁcant differences were
observed between groups with respect to nerve action
potentials.
Conclusions: In a hindlimb ischemia model, intrave-
nous H2S administration during reperfusion mitigates the
systemic markers of IRI. The moderate ischemia group
experienced the greatest beneﬁt, with no beneﬁt seen in
minimal or severe ischemia groups.
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The Effect of VEGF Activating Transcription Factor in
Therapeutic Angiogenesis and Skeletal Muscle Fiber in
the Mouse With Hindlimb Ischemia
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Medical College Hospital, Beijing, China; 2Peking Union
Meducal College Basic Research, Beiijing, ChinaObjectives: To test whether vascular endothelial
growth factor (VEGF)-activating transcription factor
(ATF) stimulating the endogenous VEGF expression pro-
duces more mature neovessels and inﬂuences skeletal mus-
cle ﬁber type remodeling.
Methods: Ischemic limbs received VEGF-ATF treat-
ment or VEGF165 or placebo treatment after unilateral
femoral artery ligation and excision. Mice were euthanized
at 7, 14, and 21 days after injection. Limb blood ﬂow was
monitored serially by laser Doppler perfusion imaging.
VEGF protein expression was examined by Western blot-
ting. Capillary density, endothelial proliferation, and
apoptosis were examined using immunohistochemical
techniques. Besides that, according to rat mesenteric artery
immunoﬂuorescence, we observed neovessels maturity
with NG-2 for pericyte coverage. Finally, skeletal muscle ﬁ-
ber type was derived from myoﬁbrillar adenosine triphos-
phatase (mATPase) staining; moreover, the myosin heavy
chain (MHC) RNA isoform was tested with real-time po-
lymerase chain reaction (PCR).
Results: (1) The purposed gene was successfully con-
structed into the PVAX1 and the PcDNA3.0 plasmid. (2)
VEGF-ATF stimulated VEGF protein expression at 7 days
after compared with the VEGF165 control group. (3)
VEGF-ATF increased better perfusion recovery, and more-
over, produced a higher capillary density. (4) Rat mesenteric
artery immunoﬂuorescence indicated that the neovessels in
the VEGF-ATF group had more maturity because of the
whole pericyte coverage. (5) ATPase staining and MHC
real-time PCR results showed VEGF-AFP and VEGF165
both performed the remodeling of the muscle ﬁber type in
the gastrocnemius and soleus.
Conclusions: Intramuscular injection of VEGF-ATF
can perform therapeutic angiogenesis in the hindlimb
ischemic mouse model; moreover, stimulating the more
mature neovessles from the integrity. In addition, the mus-
cle ﬁber type shift might supply a potential method for the
intermittent distance development for the patients with pe-
ripheral artery disease.
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Objectives: Abdominal aortic aneurysm (AAA) is a life-
threatening chronic vascular disease. Previous work showed
that AAAs are attenuated in mice deﬁcient for C-C chemo-
kine receptor type 2 (CCR2), a critical regulator of mono-
cyte mobilization and migration. We evaluated the
therapeutic effect of propagermanium (PG), a CCR2 inhib-
itor, on formation and progression of experimental AAAs.
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C57BL/6J mice via intra-aortic porcine pancreatic elastase
(PPE) infusion. PG treatment (50 mg/kg/d) was initiated
before or after AAA creation. Inﬂuences on AAAs were
evaluated using ultrasonography, histology, and ﬂuores-
cence-activated cell sorter (FACS) analyses.
Results: PG pretreatment almost completely abolished
AAA formation. PG treatment also attenuated further pro-
gression in existing AAAs. Histologically, both PG treatment
regimens preserved medial elastin and smooth muscle cells,
with reduced aortic macrophage accumulation and angio-
genesis. In FACS analyses, PG pretreatment signiﬁcantly
diminished circulating and splenic inﬂammatory monocytes
and increased them in bone marrow. In in vivo monocyte
migration assays, PG treatment reduced circulating mono-
cyte migration into aneurysmal aortae by nearly 50%.
Conclusions: Treatment with the CCR2 signaling in-
hibitor PG inhibits monocyte mobilization from bone
marrow and subsequent migration into aorta, leading to
AAA suppression. CCR2 signaling inhibition may represent
a viable strategy for clinical AAA managements.Fig. PG treatment suppresses the formation and progression of
experimental AAAs. (A): Mice were treated with PG (50 mg/kg/
day) (PG progression) or vehicle for one week prior to PPE
infusion and 2 weeks thereafter, and aortic diameters were serially
measured via ultrasonography. (B): PPE-infused mice were treated
PG (PG regression) or vehicle beginning day 4 following PPE for
10 days. Data are absolute changes in aortic diameters over those
on 3 days following PPE infusion. (C, D): Quantiﬁcation of aortic
macrophages (CD68* cells) and mural angiogenesis (CD31*
blood vessels) per aortic cross section (ACS). (E): Absolute
numbers of inﬂammatory monocytes (CD11b*, Ly-6chigh) pe-
ripheral blood (PB), bone marrow (BM) and spleen (Sp) measured
via cell suspension immunoﬂuorescence staining and ﬂow cyto-
metric analysis. (F): Effect of PG treatment on in vivo migration of
intravenously transferred ﬂuorescence RFP-tagged monocytes into
aneurysmal aortae. Migration in PG treatment group is presented
as the percentage of monocyte migration in the vehicle group in
which the migration was set at 100%. LN: lymph nodes. All data
are mean and standard deviation from 5-8 mice in each group.
Non-parameteric Mann-Whitney test or two-way ANOVA fol-
lowed by Newman Keuls post test, *P<0.05 and **P<0.01
compared with vehicle group.
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Objectives: Although uncomplicated acute type B
aortic dissections are often medically managed with good
outcomes, a subset will develop subacute or chronic aneu-
rysmal dilatation. We hypothesize that computational ﬂuid
dynamics (CFD) simulations may be useful in identifying
patients at risk for this complication.
Methods: Patients with acute type B dissection
complicated by rapidly expanding aortic aneurysms
(n ¼ 7) were compared with patients with stable aortic
diameters (n ¼ 7). Three-dimensional patient-speciﬁc
dissection geometries were generated from computed
tomography angiography and used in CFD simulations of
pulsatile blood ﬂow. Hemodynamic parameters, including
false lumen ﬂow and wall shear stress, were compared.
Results: Patients with rapid aneurysmal degeneration
had a growth rate of 5.3 6 2.7 mm/mon compared with
those with stable aortic diameters who had rates of 0.2 6
0.02 mm/mon. Groups did not differ in initial aortic
diameter (36.1 6 2.9 vs 34.4 6 3.6 mm; P ¼ .122) or
false lumen size (22.6 6 2.9 vs 20.2 6 4.5 mm; P ¼
.224). In patients with rapidly expanding aneurysms, a
greater percentage of total ﬂow passed through the false
lumen (78.3% 6 9.3% vs 56.3% 6 11.8%; P ¼ .016).
The time-averaged wall shear stress on the aortic wall
was also signiﬁcantly higher (12.6 6 3.7 vs 7.4 6 2.8
Pa; P ¼ .028; Fig).
Conclusions: Hemodynamic parameters derived
from CFD simulations of acute type B aortic dissections
